SOUTH SAN FRANCISCO, Calif., Dec. 8, 2017 /PRNewswire/ — Rigel Pharmaceuticals (Nasdaq: RIGL) today announced that on December 4, 2017 the Compensation Committee of Rigel’s Board of Directors approved the grant of inducement stock options to purchase an aggregate of 60,000 shares of…
